Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

@article{Yamashita2001ImmunologicAV,
  title={Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.},
  author={Traci E. Yamashita and John P. Phair and Alvaro Muňoz and Joseph B. Margolick and Roger Detels and Stephen J. O'Brien and John W Mellors and Steven M. Wolinsky and Lisa Paula Jacobson},
  journal={AIDS},
  year={2001},
  volume={15 6},
  pages={735-46}
}
OBJECTIVES To evaluate prior antiretroviral therapy experience and host characteristics as determinants of immunologic and virologic response to highly active antiretroviral therapy (HAART). METHODS We studied 397 men from the Multicenter AIDS Cohort Study (MACS) who initiated HAART between October 1995 and March 1999. CD4 cell count and HIV-1 RNA responses to HAART were measured at the first visit following HAART (short-term) and extending from the first visit to approximately 33 months… CONTINUE READING